Around the Net

Mylan Targeted In Two EpiPen Probes

The maker of EpiPen emergency allergy injectors, under a microscope for repeatedly jacking up the price of the life-saving device, revealed it is a target of two price-related probes by federal agencies and has had its premises searched. The came after Mylan reported a third-quarter loss, mainly due to a settlement for overcharging the federal government.

Read the whole story at Associated Press »

Next story loading loading..